Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes

Overview of attention for article published in Frontiers in Pharmacology, August 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 42,926 followers.

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes https://t.co/w17h3bn1wG

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes. https://t.co/k2etW1uiUk https://t.co/s6mt8WZhvl

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes. https://t.co/qSTp7atxV4 https://t.co/XX1fZ8SGSy

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes https://t.co/gTO9TbHGDA https://t.co/J9OjSQX2vM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.